KRAS and breast neoplasm: By using a K-RAS knockdown-based strategy, the authors demonstrated that in a panel of lung and breast tumor cell lines, not all K-RAS mutated cells were dependent on K-RAS signaling, and some cells carrying wild-type K-RAS exhibited a K-RAS dependency.